BioSpace News Archive

Atlantic Health System, an integrated health care delivery system, today announced a partnership with theTranslational Genomics Research Institute (TGen)(TGen), an affiliate of City of Hope, and Origin Commercial Ventures to create a new platform to deliver economically viable immunotherapies and other breakthrough cancer treatments to the region through expedited access and novel payment options.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Food and Drug Administration (FDA) has approved Hemlibra® (emicizumab-kxwh) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors.

Spinal Singularity announced that the company was awarded a Phase II SBIR grant from the National Institute of Health (NIH)

BioAtla, LLC, a global biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, congratulates James Allison, Ph.D., for receiving the 2018 Nobel Prize in Physiology or Medicine recognizing his leading role in launching an effective new way to attack cancer by treating the immune system.

After having successfully treated 14 patients, a team of researchers at Université Laval’s Research Centre: The Tissue Engineering Laboratory (LOEX), led by professors at Université Laval and researchers at the CHU de Québec-Université Laval Research Centre, François A. Auger, Lucie Germain and Véronique Moulin, has just published their results pertaining to a new technique for burn patient treatment in the European Cells and Materials (eCM) Journal.

Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will conduct four continuing education symposia in conjunction with AJMC® at the Academy of Managed Care Pharmacy (AMCP) Nexus: Preparing for the Next Generation of Care, which will take place Oct. 22-25 at the Orlando World Center Marriott in Orlando, Florida, announced Jim Palatine, RPh, MBA, president of PTCE.

HealthStartNJ, established by New Jersey Health Foundation (NJHF) made a financial investment of $50,000 in Paracelsus Neuroscience I, LLC (“Paracelsus”), a startup company founded by Roland G.W. Staal, PhD that focuses on the study and therapeutics of neuropathic pain, announced James M. Golubieski, president of NJHF.

Governments, doctors, teachers and counselors have taken arms against what might be one of the most unconquerable mental health issues of our age: depression. One-on-one counseling, wellness initiatives, and online information are our only current means of non-biological defense.

Medical and pharmacy claims data will track how long patients stay on Stelara®, informing Prime’s clinical programs aimed at better health outcomes

Researchers in Columbia, South America, conducted a retrospective observational study within six hospitals to identify risk factors of maternal mortality in mechanically ventilated pregnant patients.